Liposarcoma future or investigational therapies

Jump to navigation Jump to search

Liposarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Liposarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Liposarcoma future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liposarcoma future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liposarcoma future or investigational therapies

CDC on Liposarcoma future or investigational therapies

Liposarcoma future or investigational therapies in the news

Blogs on Liposarcoma future or investigational therapies

Directions to Hospitals Treating Liposarcoma

Risk calculators and risk factors for Liposarcoma future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Current clinical trials of liposarcoma are promising and genetic basis of the disease is studied extensively to find an effective treatment for this disease.

Future or Investigational Therapies

Clinical trials

Tests and treatment go through four different phases of clinical trail to test the benefits of it. The four phases of treatment are as follows.[1]

  • Phase 1 trial

It aims to find out the best dose of a new drug with the lowest side effects

  • Phase 2 trial

Asses whether a drug works for a specific cancer or not

  • Phase 3 trial

Compares a new drug to a standard treatment

  • Phase 4 trail

It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease.

SARC trials

Clinical trails are being conducted by SARC on soft tissue tumors as a part of furute investigationa therapies.[2]

23andMe research project

They work with the patient community to find the genetic markers of sarcoma. [3]

References

  1. "NCCN".
  2. "SARC trials".
  3. "Project".

Template:WikiDoc Sources